Build the competitive set, benchmark your target product profile against the standard of care and the pipeline, sequence the right indications, and time it all around the catalysts that will move the market.
A launch plan is a snapshot: competitive sets built by hand, TPP benchmarks in a spreadsheet, indication and reimbursement signals scattered across tools, and a catalyst calendar that's stale the week after it's made.
The market keeps moving, but the plan doesn't. Keeping it current means painful manual re-work every quarter, and in between, you're falling behind.
Build a new product plan on current market conditions, then let One Zyme track the dynamics that matter, competitive moves, trial catalysts, reimbursement and pipeline shifts, and update your plan automatically as they change.
No painful quarterly re-work, no falling behind. The plan stays live, and every claim traces to its source.
One Zyme assembles the comparable assets, approved and in development, and scores your candidate against them attribute by attribute, so the differentiation case is grounded in evidence, not assertion.
Not every indication deserves to be first. One Zyme scores each candidate indication on unmet need, competitive timing, trial feasibility, and reimbursement path, then recommends the launch-and-expand sequence that compounds.
Each indication is scored on four weighted dimensions, then ordered to maximize the franchise, not just the first approval.
Competitor readouts, regulatory decisions, guideline updates, and payer cycles all reshape a launch window. One Zyme maintains the catalyst calendar for your space and keeps it current as the landscape shifts.
One Zyme plots every comparable asset by differentiation and unmet need at once. The right position isn't just the open space, it's the open space where patients still have no good option.
Assemble every comparable asset, trial, and label, approved and in development, resolved to the same entities and continuously refreshed.
Score your profile against the standard of care and the pipeline, attribute by attribute, to surface the defensible differentiation case.
Rank indications by need and feasibility, then time launch and expansion around the catalysts that will move the market.
Every planning workflow runs on the same agents, data, and evidence trail that power the rest of the platform.
Explore Models & Data →Get a strategic briefing tailored to your asset, target product profile, and indication priorities.
